Head to head

Splendor X vs Thunder (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: Catalog new-price ranges: Splendor X, $130k–$165k; Thunder, $110k–$150k. Check the source notes and request current quotes.
Practice fit: Both are listed under dual-wavelength laser. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

Dual-wavelength laser

View full device profile →

Device B

Dual-wavelength laser

View full device profile →

Price comparison

Price comparison: Lumenis Splendor X vs Quanta System Thunder (MT)
Attribute	Lumenis Splendor X	Quanta System Thunder (MT)
New price range	$130k–$165kSource not documented	$110k–$150kSource not documented
Used asking range	$70k–$110kSource not documented	$60k–$90kSource not documented
Payback calculator	View ROI calculator	View ROI calculator
Next step

New price range

Lumenis Splendor X: $130k–$165kSource not documented
Quanta System Thunder (MT): $110k–$150kSource not documented

Used asking range

Lumenis Splendor X: $70k–$110kSource not documented
Quanta System Thunder (MT): $60k–$90kSource not documented

Payback calculator

Lumenis Splendor X: View ROI calculator
Quanta System Thunder (MT): View ROI calculator

Next step

Lumenis Splendor X

Quanta System Thunder (MT)

Consumable economics

Consumable economics: Lumenis Splendor X vs Quanta System Thunder (MT)
Attribute	Lumenis Splendor X	Quanta System Thunder (MT)
Consumable cost / lock-in	No per-treatment disposable. The recurring cost is wear parts — handpiece lenses, flashlamp, protective windows, ceramic reflector, Nd:YAG and alexandrite rods, fibre window. Not published — Lumenis does not publish US wear-part pricing and the figures previously shown carried no dated source.	—
Service cost	Not published	Not published

Consumable cost / lock-in

Lumenis Splendor X: No per-treatment disposable. The recurring cost is wear parts — handpiece lenses, flashlamp, protective windows, ceramic reflector, Nd:YAG and alexandrite rods, fibre window. Not published — Lumenis does not publish US wear-part pricing and the figures previously shown carried no dated source.
Quanta System Thunder (MT): —

Service cost

Lumenis Splendor X: Not published
Quanta System Thunder (MT): Not published

FDA clearance

FDA clearance: Lumenis Splendor X vs Quanta System Thunder (MT)
Attribute	Lumenis Splendor X	Quanta System Thunder (MT)
FDA status & indication	FDA ClearedK241407, K243445 Read FDA indication wording “The Nd:YAG 1064 Laser is intended for: • Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of Pseudofolliculitis barbae (PFB). Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types, such as Fitzpatrick I-VI, including tanned skin. • Photocoagulation and hemostasis of benign pigmented and vascular lesions such as, but not limited to, port-wine stains, hemangioma, warts, telangiectasia, rosacea, venous lake, leg veins and spider veins. • Coagulation and hemostasis of soft tissue. • Treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sunspots), cafe au lait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for benign pigmented lesions to reduce lesion size, for patients with benign lesions that would potentially benefit from aggressive treatment, and for patients with benign lesions that have not responded to other laser treatments. • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. • Treatment of wrinkles. • Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes, Trichophyton rubrum and T. mentagrophytes, and/or yeast Candida Albicans, etc.). The Alexandrite 755 laser is intended for: • Temporary hair reduction. • Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types, such as Fitzpatrick I – VI, including tanned skin. • Treatment of benign pigmented lesions. • Treatment of wrinkles. • Photocoagulation of dermatological benign vascular lesions (such as port-wine stains, hemangiomas, telangiectasias).”	FDA ClearedK171711 Read FDA indication wording “The THUNDER Family is intended for use in aesthetic, cosmetic and surgical applications requiring incision, excision, ablation, vaporization and coagulation of body soft tissues in the medical specialties of dermatology, general, plastic and oral surgery as follows. 1064 nm (pulsed) Dermatology/Plastic Surgery: Intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangectasia, rosacea, venous lake, leg veins, spider veins and poikiloderma of civatte; and treatment of benign cutaneous lesions such as warts, scars, striae and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratosis and plaques. The laser is also indicated for the treatment of wrinkles such as, but not limited to, periocular and perioral wrinkles. The laser is also indicated for the treatment of facial wrinkles. Additionally, the laser is indicated for the treatment of pseudofolliculitis barbae (PFB) and for stable long-term, or permanent hair reduction. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing when measured at 6, 9 and 12 months after the completion of a treatment regime. It is indicated for the reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. The laser is also indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. It is indicated for use on all skin types (Fitzpatrick I-VI) including tanned skin, and the removal and permanent reduction of unwanted hair in Fitzpatrick I-VI, including suntanned skin types. 755 nm (pulsed): Indicated for stable long-term, or permanent hair reduction. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing when measured 6, 9, or 12 months after the completion of a treatment regime. It is used for all skin types (Fitzpatrick I-VI) including tanned skin. It is also indicated for the treatment of vascular lesions, benign pigmented lesions, and wrinkles.”

FDA status & indication

Lumenis Splendor X: FDA ClearedK241407, K243445
Read FDA indication wording
“The Nd:YAG 1064 Laser is intended for: • Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of Pseudofolliculitis barbae (PFB). Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types, such as Fitzpatrick I-VI, including tanned skin. • Photocoagulation and hemostasis of benign pigmented and vascular lesions such as, but not limited to, port-wine stains, hemangioma, warts, telangiectasia, rosacea, venous lake, leg veins and spider veins. • Coagulation and hemostasis of soft tissue. • Treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sunspots), cafe au lait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for benign pigmented lesions to reduce lesion size, for patients with benign lesions that would potentially benefit from aggressive treatment, and for patients with benign lesions that have not responded to other laser treatments. • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. • Treatment of wrinkles. • Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes, Trichophyton rubrum and T. mentagrophytes, and/or yeast Candida Albicans, etc.). The Alexandrite 755 laser is intended for: • Temporary hair reduction. • Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types, such as Fitzpatrick I – VI, including tanned skin. • Treatment of benign pigmented lesions. • Treatment of wrinkles. • Photocoagulation of dermatological benign vascular lesions (such as port-wine stains, hemangiomas, telangiectasias).”
Quanta System Thunder (MT): FDA ClearedK171711
Read FDA indication wording
“The THUNDER Family is intended for use in aesthetic, cosmetic and surgical applications requiring incision, excision, ablation, vaporization and coagulation of body soft tissues in the medical specialties of dermatology, general, plastic and oral surgery as follows. 1064 nm (pulsed) Dermatology/Plastic Surgery: Intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangectasia, rosacea, venous lake, leg veins, spider veins and poikiloderma of civatte; and treatment of benign cutaneous lesions such as warts, scars, striae and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratosis and plaques. The laser is also indicated for the treatment of wrinkles such as, but not limited to, periocular and perioral wrinkles. The laser is also indicated for the treatment of facial wrinkles. Additionally, the laser is indicated for the treatment of pseudofolliculitis barbae (PFB) and for stable long-term, or permanent hair reduction. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing when measured at 6, 9 and 12 months after the completion of a treatment regime. It is indicated for the reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. The laser is also indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. It is indicated for use on all skin types (Fitzpatrick I-VI) including tanned skin, and the removal and permanent reduction of unwanted hair in Fitzpatrick I-VI, including suntanned skin types. 755 nm (pulsed): Indicated for stable long-term, or permanent hair reduction. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing when measured 6, 9, or 12 months after the completion of a treatment regime. It is used for all skin types (Fitzpatrick I-VI) including tanned skin. It is also indicated for the treatment of vascular lesions, benign pigmented lesions, and wrinkles.”

Which chains run each

Which chains run each: Lumenis Splendor X vs Quanta System Thunder (MT)
Attribute	Lumenis Splendor X	Quanta System Thunder (MT)
Chain adoption	0 recorded pairings	0 recorded pairings
Chains using it	—	—
Approved reviews	0	0

Chain adoption

Lumenis Splendor X: 0 recorded pairings
Quanta System Thunder (MT): 0 recorded pairings

Chains using it

Lumenis Splendor X: —
Quanta System Thunder (MT): —

Approved reviews

Lumenis Splendor X: 0
Quanta System Thunder (MT): 0

Specs and platform

Specs and platform: Lumenis Splendor X vs Quanta System Thunder (MT)
Attribute	Lumenis Splendor X	Quanta System Thunder (MT)
Manufacturer	Lumenis	Quanta System
Built by (OEM)	Lumenis Be Ltd.	Quanta System S.p.A.
Category	Dual-wavelength laser	Dual-wavelength laser
Technology	755+1064nm BLEND X square spot	755+1064nm high-power blended
Launch year	2018	2019
Status	Current	Current
Manufacturer source record	No linked source on file.	No linked source on file.

Manufacturer

Lumenis Splendor X: Lumenis
Quanta System Thunder (MT): Quanta System

Built by (OEM)

Lumenis Splendor X: Lumenis Be Ltd.
Quanta System Thunder (MT): Quanta System S.p.A.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Cutera Excel HR

Dual-wavelength laser

New: $95k–$135k

Lutronic Clarity II

Dual-wavelength laser

New: $100k–$140k

Quanta System Duetto MT / MT Evo

Dual-wavelength laser

New: $80k–$120k

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.